Sökning: "malignancy"
Visar resultat 16 - 20 av 402 avhandlingar innehållade ordet malignancy.
16. Neutropenic fever during treatment of hematological malignancy : etiology and diagnostics
Sammanfattning : Fever is the principal and sometimes the only manifestation of serious infection in the neutropenic patient because signs of inflammation may be minimal or absent in this group of patients. The aim of this thesis was to improve the clinical management of the febrile neutropenic patient. LÄS MER
17. Genetic studies of susceptibility to inflammation, autoimmunity, and hematological malignancy
Sammanfattning : The immune system represents the body’s defense against infectious organisms. Inborn defects of the immune system, called primary immunodeficiencies (PIDs), are a heterogeneous group of Mendelian disorders. Clinically, PIDs can cause isolated to broad susceptibility to pathogens, severe hyperinflammation, autoimmunity, allergy, and cancer. LÄS MER
18. Bruton tyrosine kinase in immunodeficiency and in B-cell malignancy
Sammanfattning : BTK inhibitors have induced high response rates in the treatment of leukemias and lymphomas. Ibrutinib is the first-in-class US Food and Drug Administration (FDA)-approved BTK covalent inhibitor to treat chronic lymphocytic leukemia (CLL). However, a sub-group of patients develops resistance to ibrutinib therapy. LÄS MER
19. Biliary strictures in primary sclerosing cholangitis : aspects on inflammation and malignancy
Sammanfattning : Primary sclerosing cholangitis (PSC) is a rare liver disease that is characterized by chronic inflammation of bile ducts with development of fibrosis and strictures. The pathogenic mechanisms involved in this disease are insufficiently understood. LÄS MER
20. Ovarian tumors. Prevalence, malignancy risk and significance of the Plasminogen activation system
Sammanfattning : The aims were to assess the prevalence of ovarian tumors in fertile asymptomatic women and to evaluate the risk of ovarian cancer in women with a history of benign ovarian tumors and endometriosis. In order to search for biomarkers in ovarian tumors, the plasminogen activating (PA) system was studied. LÄS MER